Key result
UT deletion increases atherosclerosis and serum lipids but decreases hepatic steatosis in ApoE knockout mice.
Why the study?
Does Urotensin II receptor gene deletion increase atherosclerosis and hyperlipidemia in ApoE knockout mice fed a high-fat diet?
Does Urotensin II receptor gene deletion increase atherosclerosis and hyperlipidemia in ApoE knockout mice fed a high-fat diet?
p-value: p=<0.05
Urotensin II receptor deletion in ApoE knockout mice paradoxically worsens hyperlipidemia and atherosclerosis while reducing hepatic steatosis, likely via downregulation of hepatic ACAT1 and lipoprotein uptake.
RATIONALE: Expression of the vasoactive peptide Urotensin II (UII) is elevated in a number of cardiovascular diseases. OBJECTIVE: Here, we sought to determine the effect of UII receptor (UT) gene deletion in a mouse model of atherosclerosis. METHODS AND RESULTS: UT knockout (KO) mice were crossed with ApoE KO mice to generate UT/ApoE double knockout (DKO) mice. Mice were placed on a high-fat Western-type diet for 12 weeks. We evaluated the degree of atherosclerosis and hepatic steatosis by histology. In addition, serum glucose, insulin, and lipids were determined. DKO mice exhibited significantly increased atherosclerosis compared to ApoE KO mice (P<0.05). This was associated with a significant increase in serum insulin and lipids (P<0.001) but a decrease in hepatic steatosis (P<0.001). UT gene deletion led to a significant increase in systolic pressure and pulse pressure. RT-PCR and immunoblot analyses showed significant reductions in hepatic scavenger receptors, nuclear receptors, and acyl-CoA:cholesterol acyltransferase (ACAT1) expression in DKO mice. UII induced a significant increase in intracellular cholesteryl ester formation in primary mouse hepatocytes, which was blocked by the MEK inhibitor, PD98059. Hepatocytes of UTKO mice showed a significant reduction in lipoprotein uptake compared to wild-type mice. CONCLUSIONS: We propose that UT gene deletion in an ApoE-deficient background promotes downregulation of ACAT1, which in turn attenuates hepatic lipoprotein receptor-mediated uptake and lipid transporter expression. As the liver is the main organ for uptake of lipoprotein-derived lipids, DKO leads to an increase in hyperlipidemia, with a concomitant decrease in hepatic steatosis, and consequently increased atherosclerotic lesion formation. Furthermore, the hypertension associated with UT gene deletion is likely to contribute to the increased atherosclerotic burden.
No takes yet. Share an insight, caveat, or question.
Bousette et al. (2009) studied Atherosclerosis. UT gene deletion (UT/ApoE double knockout) vs. ApoE knockout mice was evaluated on Degree of atherosclerosis (p=<0.05). UT gene deletion in ApoE knockout mice fed a high-fat diet significantly increased atherosclerosis (P<0.05) and serum lipids (P<0.001), while decreasing hepatic steatosis (P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: